Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)
Close on Nov 18, 2026Market cap $115.53MP/E –Yield –
Pulmonx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Pulmonx's shares outstanding was 42M at Jun 30, 2026. For fiscal 2025 it was 41M, up 4.0% from the year before. The highest annual figure on record is 41M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41M | +4.0% |
| FY2024 | Dec 31, 2024 | 39M | +3.0% |
| FY2023 | Dec 31, 2023 | 38M | +2.4% |
| FY2022 | Dec 31, 2022 | 37M | +2.7% |
| FY2021 | Dec 31, 2021 | 36M | +254.7% |
| FY2020 | Dec 31, 2020 | 10M | +473.4% |
| FY2019 | Dec 31, 2019 | 2M | +6.1% |
| FY2018 | Dec 31, 2018 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 42M | +5.0% |
| Q1 FY2026 | Mar 31, 2026 | 42M | +4.9% |
| Q4 FY2025 | Dec 31, 2025 | 41M | +4.6% |
| Q3 FY2025 | Sep 30, 2025 | 41M | +4.2% |
| Q2 FY2025 | Jun 30, 2025 | 40M | +3.8% |
| Q1 FY2025 | Mar 31, 2025 | 40M | +3.4% |
| Q4 FY2024 | Dec 31, 2024 | 40M | +3.1% |
| Q3 FY2024 | Sep 30, 2024 | 39M | +3.0% |
| Q2 FY2024 | Jun 30, 2024 | 39M | +3.0% |
| Q1 FY2024 | Mar 31, 2024 | 39M | +2.8% |
| Q4 FY2023 | Dec 31, 2023 | 38M | +2.7% |
| Q3 FY2023 | Sep 30, 2023 | 38M | +2.5% |
| Q2 FY2023 | Jun 30, 2023 | 38M | +2.2% |
| Q1 FY2023 | Mar 31, 2023 | 38M | +2.1% |
| Q4 FY2022 | Dec 31, 2022 | 37M | +2.0% |
| Q3 FY2022 | Sep 30, 2022 | 37M | +2.0% |
| Q2 FY2022 | Jun 30, 2022 | 37M | +2.7% |
| Q1 FY2022 | Mar 31, 2022 | 37M | +4.1% |
| Q4 FY2021 | Dec 31, 2021 | 37M | +1201.8% |
| Q3 FY2021 | Sep 30, 2021 | 36M | +1783.3% |
| Q2 FY2021 | Jun 30, 2021 | 36M | +1790.3% |
| Q1 FY2021 | Mar 31, 2021 | 35M | +1777.2% |
| Q3 FY2020 | Sep 30, 2020 | 3M | +56.4% |
| Q2 FY2020 | Jun 30, 2020 | 2M | – |
| Q1 FY2020 | Mar 31, 2020 | 2M | – |
| Q4 FY2019 | Dec 31, 2019 | 2M | – |
| Q3 FY2019 | Sep 30, 2019 | 2M | – |
See a number that looks wrong?